1
|
Tajudeen H, Ha SH, Hosseindoust A, Mun JY, Park S, Park S, Choi P, Hermes RG, Taechavasonyoo A, Rodriguez R, Kim J. Effect of dietary inclusion of Bacillus-based probiotics on performance, egg quality, and the faecal microbiota of laying hen. Anim Biosci 2024; 37:689-696. [PMID: 38271980 PMCID: PMC10915221 DOI: 10.5713/ab.23.0299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2023] [Revised: 10/09/2023] [Accepted: 11/11/2023] [Indexed: 01/27/2024] Open
Abstract
OBJECTIVE Our study examined the impact of propriety blends of Bacillus strain probiotics on the performance, egg quality, and faecal microflora of laying hens. METHODS A total of 183 Institut de selection Animale (ISA) brown laying hens aged 23 weeks with an average body weight of 1,894±72 g were randomly allocated into 3 groups as control (corn-soybean meal based diet, CON), 0.5 g/kg Enterosure probiotics (ET1, 3×108 colony-forming unit [CFU]/kg feed), and 5 g/kg Enterosure probiotics (ET2, 3×109 CFU/kg feed) administered in mashed form. At the completion of each phase hen day egg production (HDEP), average egg weight (AEW), feed intake, and faecal microbiota were evaluated. RESULTS HDEP and AEW were higher (p<0.05) in the ET2-supplemented diet in phase 3 (week 9 to 12) compared with CON. Egg mass (EM) was higher (p<0.05) in phase 2 at ET2, and also higher (p<0.05) in phase 3 at the ET1 and ET2-supplemented diets compared with CON. Feed conversion ratio was lower (p<0.05) in phase 3 at the ET1 and ET2-supplemented diets, with ET2 being the lowest compared with ET1 and CON. Yolk colour was higher (p<0.05) in the ET-supplemented diets at phase 3 compared with CON. Bifidobacterium spp. was higher (p<0.05) in the ET2- supplemented diet compared with CON in phase 2, while in In phase 3, Lactobacillus spp. and Bifidobacterium spp. were higher (p<0.05) in the ET-supplemented diets compared with CON. Coliforms were lower (p<0.05) in the ETsupplemented diets compared with CON in phase 3. CONCLUSION The propriety blends of Bacillus strain probiotics supplements at 0.5 g/kg and 5 g/kg could improve the production and quality of eggs with more significance at 5 g/kg for HDEP, AEW and EM, which was achieved via the increase of beneficial microbiomes such as Lactobacillus spp., Bifidobacterium spp., and the decrease of pathogenic microbiomes like Escherichia coli and Coliforms which was speculated to improve gut barrier function and the reproductive hormone.
Collapse
Affiliation(s)
- Habeeb Tajudeen
- Department of Animal Industry Convergence, Kangwon National University, Chuncheon, 24341,
Korea
| | - Sang Hun Ha
- Department of Animal Industry Convergence, Kangwon National University, Chuncheon, 24341,
Korea
| | - Abdolreza Hosseindoust
- Department of Animal Industry Convergence, Kangwon National University, Chuncheon, 24341,
Korea
| | - Jun Young Mun
- Department of Animal Industry Convergence, Kangwon National University, Chuncheon, 24341,
Korea
| | - Serin Park
- Department of Animal Industry Convergence, Kangwon National University, Chuncheon, 24341,
Korea
| | - SangIn Park
- Department of Animal Industry Convergence, Kangwon National University, Chuncheon, 24341,
Korea
| | - PokSu Choi
- Department of Animal Industry Convergence, Kangwon National University, Chuncheon, 24341,
Korea
| | - Rafael Gustavo Hermes
- Kemin Industries Inc Headquarters, 1900 Scott Ave Des Moines, Des Moines, IA, 50317,
USA
| | | | - Raquel Rodriguez
- Kemin Industries Inc Headquarters, 1900 Scott Ave Des Moines, Des Moines, IA, 50317,
USA
| | - JinSoo Kim
- Department of Animal Industry Convergence, Kangwon National University, Chuncheon, 24341,
Korea
| |
Collapse
|
2
|
Jacques-Aviñó C, Alarcón Guitiérrez M, Barbera MJ, Fuertes I, Martin-Ezquerra G, Lopez-Contreras J, Vives Á, Rodriguez R, Ros M, Rius C, de Olalla PG. Epidemiological Characteristics and Factors Associated with Repeat Sexually Transmitted Infections in Barcelona, Spain Over a Decade. Arch Sex Behav 2024; 53:735-744. [PMID: 37875628 PMCID: PMC10844332 DOI: 10.1007/s10508-023-02711-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/09/2022] [Revised: 09/12/2023] [Accepted: 09/15/2023] [Indexed: 10/26/2023]
Abstract
In the last few years, the frequency of sexually transmitted infections (STI) has increased, as has the number of people with multiple infections. The aim of our study was to describe the epidemiological characteristics of persons with repeated bacterial STI and to determine the risk factors for these episodes in persons living in Barcelona during the period 2007-2018. We studied all cases of bacterial STI included in the STI registry of Barcelona. Repeated STI were defined as a diagnosis of gonorrhea, syphilis, or lymphogranuloma venereum (LGV) after a first episode of one of these infections. Analysis was stratified by sex and place of birth. The factors associated with time to reinfection were determined by Kaplan-Meier estimates, while the factors associated with risk of infection were determined by a Cox proportional hazards model. Of 9927 persons with a diagnosis of bacterial STI, 1690 (17.0%) had at least two episodes of STI during the study period. On multivariate analysis, repeat STI were independently associated with male sex assigned at birth (HR: 3.45; 95%CI 2.22-5.36), age less than 34 years (HR: 1.22; 95%CI 1.10-1.35); gay, bisexual, and other men who have sex with men, and transgender o transsexual woman (GBSMS/Trans) (HR: 4.03; 95%CI 3.24-5.03), having gonorrhea as first diagnosis (HR:1.49, 95%CI 1.34-1.66) or LGV (HR:1.75; 95%CI 1.47-2.08) and coinfection with HIV (HR:1.98; 95%CI 1.78-2.21). Sexual health programs should be strengthened to prevent STI and reinfection in key populations.
Collapse
Affiliation(s)
- Constanza Jacques-Aviñó
- Servei d'Epidemiologia, Agència de Salut Pública de Barcelona, Barcelona, Spain.
- Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina, Gran Via Corts Catalanes, 587, àtic, 08007, Barcelona, Spain.
- Universitat Autònoma de Barcelona, Bellaterra, Cerdanyola del Vallès (Barcelona), Bellaterra, Spain.
- Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain.
| | - Miguel Alarcón Guitiérrez
- Servei d'Epidemiologia, Agència de Salut Pública de Barcelona, Barcelona, Spain
- Universitat Autònoma de Barcelona, Bellaterra, Cerdanyola del Vallès (Barcelona), Bellaterra, Spain
- Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain
| | - María Jesús Barbera
- Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - Irene Fuertes
- Dermatology Department, Hospital Clinic, Barcelona, Spain
| | - Gemma Martin-Ezquerra
- Dermatology Department, Institut Hospital del Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain
| | - Joaquín Lopez-Contreras
- Infectious Diseases Unit-Internal Medicine Department, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain
| | | | - Raquel Rodriguez
- Servei d'Epidemiologia, Agència de Salut Pública de Barcelona, Barcelona, Spain
| | - Miriam Ros
- Servei d'Epidemiologia, Agència de Salut Pública de Barcelona, Barcelona, Spain
| | - Cristina Rius
- Servei d'Epidemiologia, Agència de Salut Pública de Barcelona, Barcelona, Spain
- Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain
- Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
- Universitat Pompeu Fabra, Barcelona, Spain
| | - Patricia Garcia de Olalla
- Servei d'Epidemiologia, Agència de Salut Pública de Barcelona, Barcelona, Spain
- Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain
- Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
- Universitat Pompeu Fabra, Barcelona, Spain
| |
Collapse
|
3
|
Oliva Ramirez J, Lee Y, Rodriguez R, Tomczak K, Zhou X, Ravi V, Conley A, Ingram D, Livingston J, Ludwing J, Somaiah N, Haymaker C. 103P Analysis of resected liposarcoma tumors identifies CD73 as a potential therapeutic target. ESMO Open 2023. [DOI: 10.1016/j.esmoop.2023.101140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
4
|
Lorusso R, De Piero ME, Mariani S, Di Mauro M, Folliguet T, Taccone FS, Camporota L, Swol J, Wiedemann D, Belliato M, Broman LM, Vuylsteke A, Kassif Y, Scandroglio AM, Fanelli V, Gaudard P, Ledot S, Barker J, Boeken U, Maier S, Kersten A, Meyns B, Pozzi M, Pedersen FM, Schellongowski P, Kirali K, Barrett N, Riera J, Mueller T, Belohlavek J, Lorusso R, De Piero ME, Mariani S, Di Mauro M, Folliguet T, Taccone FS, Camporota L, Swol J, Wiedemann D, Belliato M, Broman LM, Vuylsteke A, Kassif Y, Scandroglio AM, Fanelli V, Gaudard P, Ledot S, Barker J, Boeken U, Maier S, Kersten A, Meyns B, Pozzi M, Pedersen FM, Schellongowski P, Kirali K, Barrett N, Riera J, Mueller T, Belohlavek J, Lo Coco V, Van der Horst ICC, Van Bussel BCT, Schnabel RM, Delnoij T, Bolotin G, Lorini L, Schmiady MO, Schibilsky D, Kowalewski M, Pinto LF, Silva PE, Kornilov I, Blandino Ortiz A, Vercaemst L, Finney S, Roeleveld PP, Di Nardo M, Hennig F, Antonini MV, Davidson M, Jones TJ, Staudinger T, Mair P, Kilo J, Krapf C, Erbert K, Peer A, Bonaros N, Kotheletner F, Krenner Mag N, Shestakova L, Hermans G, Dauwe D, Meersseman P, Stockman B, Nobile L, Lhereux O, Nrasseurs A, Creuter J, De Backer D, Giglioli S, Michiels G, Foulon P, Raes M, Rodrigus I, Allegaert M, Jorens P, Debeucklare G, Piagnarelli M, Biston P, Peperstraete H, Vandewiele K, Germay O, Vandeweghe D, Havrin S, Bourgeois M, Lagny MG, Alois G, Lavios N, Misset B, Courcelle R, Timmermans PJ, Yilmaz A, Vantomout M, Lehaen J, Jassen A, Guterman H, Strauven M, Lormans P, Verhamme B, Vandewaeter C, Bonte F, Vionne D, Balik M, Blàha J, Lips M, Othal M, Bursa F, Spacek R, Christensen S, Jorgensen V, Sorensen M, Madsen SA, Puss S, Beljantsev A, Saiydoun G, Fiore A, Colson P, Bazalgette F, Capdevila X, Kollen S, Muller L, Obadia JF, Dubien PY, Ajrhourh L, Guinot PG, Zarka J, Besserve P, Malfertheiner MV, Dreier E, Heinze B, Akhyari P, Lichtenberg A, Aubin H, Assman A, Saeed D, Thiele H, Baumgaertel M, Schmitto JD, Ruslan N, Haverich A, Thielmann M, Brenner T, Ruhpawar A, Benk C, Czerny M, Staudacher DL, Beyersdorf F, Kalbhenn J, Henn P, Popov AF, Iuliu T, Muellenbach R, Reyher C, Rolfes C, Lotz G, Sonntagbauer M, Winkels H, Fichte J, Stohr R, Kalverkamp S, Karagiannidis C, Schafer S, Svetlitchny A, Fichte J, Hopf HB, Jarczak D, Groesdonk H, Rommer M, Hirsch J, Kaehny C, Soufleris D, Gavriilidis G, Pontikis K, Kyriakopoulou M, Kyriakoudi A, O'Brien S, Conrick-Martin I, Carton E, Makhoul M, Ben-Ari J, Hadash A, Kogan A, Kassif Lerner R, Abu-Shakra A, Matan M, Balawona A, Kachel E, Altshuler R, Galante O, Fuchs L, Almog Y, Ishay YS, Lichter Y, Gal-oz A, Carmi U, Nini A, Soroksky A, Dekel H, Rozman Z, Tayem E, Ilgiyaev E, Hochman Y, Miltau D, Rapoport A, Eden A, Kompanietz D, Yousif M, Golos M, Grazioli L, Ghitti D, Loforte A, Di Luca D, Baiocchi M, Pacini D, Cappai A, Meani P, Mondino M, Russo CF, Ranucci M, Fina D, Cotza M, Ballotta A, Landoni G, Nardelli P, Fominski EV, Brazzi L, Montrucchio G, Sales G, Simonetti U, Livigni S, Silengo D, Arena G, Sovatzis SS, Degani A, Riccardi M, Milanesi E, Raffa G, Martucci G, Arcadipane A, Panarello G, Chiarini G, Cattaneo S, Puglia C, Benussi S, Foti G, Giani M, Bombino M, Costa MC, Rona R, Avalli L, Donati A, Carozza R, Gasparri F, Carsetti A, Picichè M, Marinello A, Danzi V, Zanin A, Condello I, Fiore F, Moscarelli M, Nasso G, Speziale G, Sandrelli L, Montalto A, Musumeci F, Circelli A, Russo E, Agnoletti V, Rociola R, Milano AD, Pilato E, Comentale G, Montisci A, Alessandri F, Tosi A, Pugliese F, Giordano G, Carelli S, Grieco DL, Dell'Anna AM, Antonelli M, Ramoni E, Zulueta J, Del Giglio M, Petracca S, Bertini P, Guarracino F, De Simone L, Angeletti PM, Forfori F, Taraschi F, Quintiliani VN, Samalavicius R, Jankuviene A, Scupakova N, Urbonas K, Kapturauskas J, Soerensen G, Suwalski P, Linhares Santos L, Marques A, Miranda M, Teixeira S, Salgueiro A, Pereira F, Ketskalo M, Tsarenko S, Shilova A, Afukov I, Popugaev K, Minin S, Shelukhin D, Malceva O, Gleb M, Skopets A, Kornelyuk R, Kulikov A, Okhrimchuk V, Turchaninov A, Shelukhin D, Petrushin M, Sheck A, Mekulov A, Ciryateva S, Urusov D, Gorjup V, Golicnik A, Goslar T, Ferrer R, Martinez-Martinez M, Argudo E, Palmer N, De Pablo Sanchez R, Juan Higuera L, Arnau Blasco L, Marquez JA, Sbraga F, Fuset MP, De Gopegui PR, Claraco LM, De Ayala JA, Peiro M, Ricart P, Martinez S, Chavez F, Fabra M, Sandoval E, Toapanta D, Carraminana A, Tellez A, Ososio J, Milan P, Rodriguez J, Andoni G, Gutierrez C, Perez de la Sota E, Eixeres-Esteve A, Garcia-Maellas MT, Gutierrez-Gutierrez J, Arboleda-Salazar R, Santa Teresa P, Jaspe A, Garrido A, Castaneda G, Alcantara S, Martinez N, Perez M, Villanueva H, Vidal Gonzalez A, Paez J, Santon A, Perez C, Lopez M, Rubio Lopez MI, Gordillo A, Naranjo-Izurieta J, Munoz J, Alcalde I, Onieva F, Gimeno Costa R, Perez F, Madrid I, Gordon M, Albacete Moreno CL, Perez D, Lopez N, Martinenz D, Blanco-Schweizer P, Diez C, Perez D, Prieto A, Renedo G, Bustamante E, Cicuendez R, Citores R, Boado V, Garcia K, Voces R, Domezain M, Nunez Martinez JM, Vicente R, Martin D, Andreu A, Gomez Casal V, Chico I, Menor EM, Vara S, Gamacho J, Perez-Chomon H, Javier Gonzales F, Barrero I, Martin-Villen L, Fernandez E, Mendoza M, Navarro J, Colomina Climent J, Gonzales-Perez A, Muniz-Albaceita G, Amado L, Rodriguez R, Ruiz E, Eiras M, Grins E, Magnus R, Kanetoft M, Eidevald M, Watson P, Vogt PR, Steiger P, Aigner T, Weber A, Grunefelder J, Kunz M, Grapow M, Aymard T, Reser D, Agus G, Consiglio J, Haenggi M, Hansjoerg J, Iten M, Doeble T, Zenklusen U, Bechtold X, Faedda G, Iafrate M, Rohjer A, Bergamaschi L, Maessen J, Reis Miranda D, Endeman H, Gommers D, Meuwese C, Maas J, Van Gijlswijk MJ, Van Berg RN, Candura D, Van der Linden M, Kant M, Van der Heijden JJ, Scholten E, Van Belle-van Haren N, Lagrand WK, Vlaar AP, De Jong S, Cander B, Sargin M, Ugur M, Kaygin MA, Daly K, Agnew N, Head L, Kelly L, Anoma G, Russell C, Aquino V, Scott I, Flemming L, Gillon S, Moore O, Gelandt E, Auzinger G, Patel S, Loveridge R. In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study. Lancet Respir Med 2023; 11:151-162. [PMID: 36402148 PMCID: PMC9671669 DOI: 10.1016/s2213-2600(22)00403-9] [Citation(s) in RCA: 20] [Impact Index Per Article: 20.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/29/2022] [Revised: 09/18/2022] [Accepted: 09/23/2022] [Indexed: 11/18/2022]
Abstract
BACKGROUND Extracorporeal membrane oxygenation (ECMO) has been widely used in patients with COVID-19, but uncertainty remains about the determinants of in-hospital mortality and data on post-discharge outcomes are scarce. The aims of this study were to investigate the variables associated with in-hospital outcomes in patients who received ECMO during the first wave of COVID-19 and to describe the status of patients 6 months after ECMO initiation. METHODS EuroECMO-COVID is a prospective, multicentre, observational study developed by the European Extracorporeal Life Support Organization. This study was based on data from patients aged 16 years or older who received ECMO support for refractory COVID-19 during the first wave of the pandemic-from March 1 to Sept 13, 2020-at 133 centres in 21 countries. In-hospital mortality and mortality 6 months after ECMO initiation were the primary outcomes. Mixed-Cox proportional hazards models were used to investigate associations between patient and management-related variables (eg, patient demographics, comorbidities, pre-ECMO status, and ECMO characteristics and complications) and in-hospital deaths. Survival status at 6 months was established through patient contact or institutional charts review. This study is registered with ClinicalTrials.gov, NCT04366921, and is ongoing. FINDINGS Between March 1 and Sept 13, 2020, 1215 patients (942 [78%] men and 267 [22%] women; median age 53 years [IQR 46-60]) were included in the study. Median ECMO duration was 15 days (IQR 8-27). 602 (50%) of 1215 patients died in hospital, and 852 (74%) patients had at least one complication. Multiorgan failure was the leading cause of death (192 [36%] of 528 patients who died with available data). In mixed-Cox analyses, age of 60 years or older, use of inotropes and vasopressors before ECMO initiation, chronic renal failure, and time from intubation to ECMO initiation of 4 days or more were associated with higher in-hospital mortality. 613 patients did not die in hospital, and 547 (95%) of 577 patients for whom data were available were alive at 6 months. 102 (24%) of 431 patients had returned to full-time work at 6 months, and 57 (13%) of 428 patients had returned to part-time work. At 6 months, respiratory rehabilitation was required in 88 (17%) of 522 patients with available data, and the most common residual symptoms included dyspnoea (185 [35%] of 523 patients) and cardiac (52 [10%] of 514 patients) or neurocognitive (66 [13%] of 512 patients) symptoms. INTERPRETATION Patient's age, timing of cannulation (<4 days vs ≥4 days from intubation), and use of inotropes and vasopressors are essential factors to consider when analysing the outcomes of patients receiving ECMO for COVID-19. Despite post-discharge survival being favourable, persisting long-term symptoms suggest that dedicated post-ECMO follow-up programmes are required. FUNDING None.
Collapse
Affiliation(s)
- Roberto Lorusso
- Department of Cardio-Thoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, Netherlands; Cardiovascular Research Institute Maastricht, Maastricht, Netherlands.
| | - Maria Elena De Piero
- Department of Cardio-Thoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, Netherlands,Cardiovascular Research Institute Maastricht, Maastricht, Netherlands
| | - Silvia Mariani
- Department of Cardio-Thoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, Netherlands,Cardiovascular Research Institute Maastricht, Maastricht, Netherlands
| | - Michele Di Mauro
- Department of Cardio-Thoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, Netherlands,Cardiovascular Research Institute Maastricht, Maastricht, Netherlands
| | - Thierry Folliguet
- Department of Cardiac Surgery, Assistance Publique–Hôpitaux de Paris, Hôpitaux Universitaires Henri Mondor, Créteil, France
| | - Fabio Silvio Taccone
- Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
| | - Luigi Camporota
- Department of Adult Critical Care, Guy's and St Thomas' NHS Foundation, Health Centre for Human and Applied Physiological Sciences, London, UK
| | - Justyna Swol
- Department of Medicine, Paracelsus Medical University, Nuremberg, Germany
| | - Dominik Wiedemann
- Department of Cardiac Surgery, Medical University Hospital of Vienna, Vienna, Austria
| | - Mirko Belliato
- Anestesia e Rianimazione II Cardiopolmonare, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Policlinico San Matteo, Pavia, Italy
| | - Lars Mikael Broman
- ECMO Centre Karolinska, Karolinska University Hospital, Stockholm, Sweden,Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
| | - Alain Vuylsteke
- ECMO Retrieval Service & Critical Care, Royal Papworth Hospital, NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK
| | - Yigal Kassif
- Heart Transplantation Unit, Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Ramat Gan, Israel
| | - Anna Mara Scandroglio
- Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - Vito Fanelli
- Department of Surgical Sciences, Anesthesia and Intensive Care Medicine, Città della Salute e della Scienza Hospital, University of Turin, Turin, Italy
| | - Philippe Gaudard
- Department of Anesthesiology and Critical Care Medicine, Arnaud de Villeneuve Hospital, Centre Hospitalier Universitaire Montpellier, Montpellier, France,Le laboratoire de Physiologie et Médecine Expérimentale du Coeur et des Muscles (PhyMedExp), Université de Montpellier, INSERM, CNRS, Montpellier, France
| | - Stephane Ledot
- Intensive Care Unit, Royal Brompton & Harefield hospitals, London, UK
| | - Julian Barker
- Cardiothoracic Critical Care Unit, Whythenshawe Hospital, Manchester, UK
| | - Udo Boeken
- Department of Cardiac Surgery, Heinrich Heine University, Dusseldorf, Germany
| | - Sven Maier
- Department of Cardiovascular Surgery, Heart Center University Freiburg, Bad Krozingen, Germany,Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - Alexander Kersten
- Medizinische Klinik, Uniklinik Rheinisch-Westfälische Technische Hochschule, Aachen, Germany
| | - Bart Meyns
- Department of Cardiac Surgery, Universitair Ziekenhuis Leuven Gasthuisberg University Hospital, Leuven, Belgium
| | - Matteo Pozzi
- Department of Cardiac Surgery, Louis Pradel Hospital, Lyon, France
| | - Finn M Pedersen
- Cardiothoracic Intensive Care Unit, University Hospital, Copenhagen, Denmark
| | - Peter Schellongowski
- Department of Medicine I, Intensive Care Unit, Comprehensive Cancer Center, Center of Excellence in Medical Intensive Care, Medical University of Vienna, Vienna, Austria
| | - Kaan Kirali
- Cardiovascular Surgery Department, Kosuyolu High Specialization Education and Research Hospital, Istanbul, Türkiye
| | - Nicholas Barrett
- Department of Adult Critical Care, Guy's and St Thomas' NHS Foundation, Health Centre for Human and Applied Physiological Sciences, London, UK
| | - Jordi Riera
- Critical Care Department, Val d'Hebron Research Institute, Barcelona, Spain
| | - Thomas Mueller
- Department of Internal Medicine II, University Hospital of Regensburg, Regensburg, Germany
| | - Jan Belohlavek
- 2nd Department of Internal Medicine, Cardiovascular Medicine General Teaching Hospital, Prague, Czech Republic,1st Faculty of Medicine, Charles University, Prague, Czech Republic
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Abdiaj I, Cañellas S, Dieguez A, Linares ML, Pijper B, Fontana A, Rodriguez R, Trabanco A, Palao E, Alcázar J. End-to-End Automated Synthesis of C(sp 3)-Enriched Drug-like Molecules via Negishi Coupling and Novel, Automated Liquid-Liquid Extraction. J Med Chem 2023; 66:716-732. [PMID: 36520521 PMCID: PMC9841985 DOI: 10.1021/acs.jmedchem.2c01646] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2022] [Indexed: 12/23/2022]
Abstract
Herein, we report an end-to-end process including synthesis, work-up, purification, and post-purification with minimal human intervention using Negishi coupling as a key transformation to increase Fsp3 in bioactive molecules. The main advantages of this protocol are twofold. First, the automated sequential generation of organozinc reagents from readily available alkyl halides offers a large diversity of alkyl groups to functionalize (hetero)aryl halide scaffolds via Pd-catalyzed Negishi coupling in continuous flow. Second, a fully automated liquid-liquid extraction has been developed and successfully applied for unattended operations. The workflow was completed with mass-triggered preparative high-performance liquid chromatography HPLC, providing an efficient production line of compounds with enriched sp3 character and better drug-like properties. The modular nature allows a smooth adaptation to a wide variety of synthetic methods and protocols and makes it applicable to any medchem laboratory.
Collapse
Affiliation(s)
- Irini Abdiaj
- Discovery Chemistry, Janssen Research
and Development, Janssen-Cilag, S.A., C/ Jarama 75, E-45007Toledo, Spain
| | - Santiago Cañellas
- Discovery Chemistry, Janssen Research
and Development, Janssen-Cilag, S.A., C/ Jarama 75, E-45007Toledo, Spain
| | - Alejandro Dieguez
- Discovery Chemistry, Janssen Research
and Development, Janssen-Cilag, S.A., C/ Jarama 75, E-45007Toledo, Spain
| | - Maria Lourdes Linares
- Discovery Chemistry, Janssen Research
and Development, Janssen-Cilag, S.A., C/ Jarama 75, E-45007Toledo, Spain
| | - Brenda Pijper
- Discovery Chemistry, Janssen Research
and Development, Janssen-Cilag, S.A., C/ Jarama 75, E-45007Toledo, Spain
| | - Alberto Fontana
- Discovery Chemistry, Janssen Research
and Development, Janssen-Cilag, S.A., C/ Jarama 75, E-45007Toledo, Spain
| | - Raquel Rodriguez
- Discovery Chemistry, Janssen Research
and Development, Janssen-Cilag, S.A., C/ Jarama 75, E-45007Toledo, Spain
| | - Andres Trabanco
- Discovery Chemistry, Janssen Research
and Development, Janssen-Cilag, S.A., C/ Jarama 75, E-45007Toledo, Spain
| | - Eduardo Palao
- Discovery Chemistry, Janssen Research
and Development, Janssen-Cilag, S.A., C/ Jarama 75, E-45007Toledo, Spain
| | - Jesus Alcázar
- Discovery Chemistry, Janssen Research
and Development, Janssen-Cilag, S.A., C/ Jarama 75, E-45007Toledo, Spain
| |
Collapse
|
6
|
Rodriguez R, Miller J, Miltenberger T, Babbitt D. The Effect of Pre-Exercise Carbohydrate and Protein Ingestion on Repeated Sprint Times in a Group of Female College Track Athletes. J Acad Nutr Diet 2022. [DOI: 10.1016/j.jand.2022.08.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
7
|
Parra S, Avila A, Rivalta J, Guardiola M, Rodriguez R, Castro A. AB0124 EFFECTS OF INHIBITOR K-CARRAGEENAN ON HAECs INFLAMMATORY RESPONSE TO LDLs ISOLATED FROM SLE PATIENTS. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.4950] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BackgroundSystemic Lupus Erythematosus (SLE) is an autoimmune disease with a high risk of atherosclerosis and cardiovascular events. It was previously reported by our group that low-density lipoprotein (LDL) particles isolated from SLE patients, during an active state of the disease (‘flare’), promoted an exaggerated inflammatory response in human aortic endothelial cells (HAECs). However, the molecular mechanisms underlying this response still remain elusive.ObjectivesThe hypothesis of this study is that these SLE-LDLs would be using receptor LOX-1, associated with inflammatory conditions and altered lipoproteins, to generate the proatherogenic response in HAECs.MethodsLOX-1 pharmacological inhibitor k-carrageenan was used before the stimulation of HAECs with LDLs isolated from healthy controls (10), non-active (13), or active-SLE patients (13). Gene expression, protein, and cell migration assays were performed to evaluate HAECs inflammatory response.ResultsLOX-1 inhibition with k-carrageenan significantly reduced the expression of vascular cell adhesion molecule 1 (VCAM-1) and restored the gene expression of endothelial nitric oxide synthase (eNOS) in HAECs incubated with non-active SLE LDLs.ConclusionWhile VCAM-1 down-regulation was expected, the immediate next step derived from the observed results will be a deeper understanding of how LOX-1 inhibition may restore the endothelial ability to synthetize NO in the presence of altered LDL. This will allow gaining insight not only on the development of atherosclerosis but also on the clue mechanisms involved in the pathogenesis of SLE.Disclosure of InterestsNone declared
Collapse
|
8
|
Garg H, Dursun F, Elshabrawy A, Wang H, Rodriguez R, Pruthi D, Kaushik D, Mansour A, RODRIGUEZ RONALD. A comparative analysis of minimal invasive vs. open radical nephrectomy for stage III renal cell carcinoma. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)01077-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
9
|
Nohales G, Rodriguez R, Corcoy M, Garcia Larrosa A, Pardo A, Andolz I, Delgado G, Cecchini L. Effectiveness of ultrasound-guided obturator nerve interfascial block with an inguinal approach during transurethral resection of bladder tumour: A prospective randomized double-blinded clinical trial. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00333-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
10
|
Kieser M, Feudo D, Legg J, Rodriguez R, Schriever A, Parent-Stevens L, Allen SM, Feemster AA, Brueckl M, Walker PC, Pick A, Caward K, Oja K, McGuiggan M, Shepler B. Accommodating Pharmacy Students With Physical Disabilities During the Experiential Learning Curricula. Am J Pharm Educ 2022; 86:8426. [PMID: 35074851 PMCID: PMC8787167 DOI: 10.5688/ajpe8426] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/13/2020] [Accepted: 03/28/2021] [Indexed: 05/22/2023]
Abstract
Accommodating pharmacy students with physical disabilities during the experiential learning portion of the Doctor of Pharmacy (PharmD) curriculum can present unique challenges for pharmacy schools. The available literature regarding accommodations for pharmacy students in the experiential learning environment is sparse, leaving programs with little guidance. This commentary from the Big Ten Academic Alliance calls on the Academy to create a community of shared resources and best practice examples and offers practical suggestions for accommodating pharmacy students with mobility, vision, and auditory disabilities during introductory pharmacy practice experiences (IPPEs) and advanced pharmacy practice experiences (APPEs).
Collapse
Affiliation(s)
- Mara Kieser
- University of Wisconsin-Madison, School of Pharmacy, Madison, Wisconsin
| | - Donna Feudo
- Rutgers University, Ernest Mario School of Pharmacy, Piscataway, New Jersey
| | - Julie Legg
- The Ohio State University, College of Pharmacy, Columbus, Ohio
| | - Raquel Rodriguez
- University of Minnesota, College of Pharmacy, Minneapolis, Minnesota
| | - Allison Schriever
- University of Illinois at Chicago, College of Pharmacy, Chicago, Illinois
| | | | - Sheila M Allen
- University of Illinois at Chicago, College of Pharmacy, Chicago, Illinois
| | | | - Mark Brueckl
- University of Maryland, School of Pharmacy, Baltimore, Maryland
| | - Paul C Walker
- University of Michigan, College of Pharmacy, Ann Arbor, Michigan
| | - Amy Pick
- University of Nebraska Medical Center, College of Pharmacy, Omaha, Nebraska
| | - Kate Caward
- Purdue University, College of Pharmacy, West Lafayette, Indiana
| | - Katie Oja
- University of Minnesota, College of Pharmacy, Minneapolis, Minnesota
| | - Mary McGuiggan
- University of Minnesota, College of Pharmacy, Minneapolis, Minnesota
| | - Brian Shepler
- Purdue University, College of Pharmacy, West Lafayette, Indiana
| |
Collapse
|
11
|
Akie T, Gupta M, Rodriguez R, Hendey G, Mower W. 274 Characteristics of Intracranial Injury in Pediatric Patients in the National Emergency X-Radiography Utilization Study. Ann Emerg Med 2021. [DOI: 10.1016/j.annemergmed.2021.09.287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
12
|
Devin J, Cañeque T, Lin Y, Mondoulet L, Veyrune J, Abouladzé M, Garcia de Paco E, Gadacha O, Cartron G, Pasero P, Bret C, Rodriguez R, Moreaux J. IRONOMYCIN KILLS DIFFUSE LARGE B‐CELL LYMPHOMA CELLS BY TARGETING CELLULAR IRON HOMEOSTASIS. Hematol Oncol 2021. [DOI: 10.1002/hon.79_2881] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- J. Devin
- IGH‐CNRS‐UMR 9002 Institute of Human Genetics Montpellier France
| | - T. Cañeque
- CNRS UMR 3666 INSERM U1143 Chemical Biology of Cancer Laboratory Paris France
| | - Y.‐L. Lin
- IGH‐CNRS‐UMR 9002 Institute of Human Genetics Montpellier France
| | | | | | - M. Abouladzé
- IGH‐CNRS‐UMR 9002 Institute of Human Genetics Montpellier France
| | | | - O. Gadacha
- IGH‐CNRS‐UMR 9002 Institute of Human Genetics Montpellier France
| | - G. Cartron
- CHU Montpellier Clinical Hematology Montpellier France
| | - P. Pasero
- IGH‐CNRS‐UMR 9002 Institute of Human Genetics Montpellier France
| | - C. Bret
- CHU Montpellier Biological Hematology Montpellier France
| | - R. Rodriguez
- CNRS UMR 3666 INSERM U1143 Chemical Biology of Cancer Laboratory Paris France
| | - J. Moreaux
- IGH‐CNRS‐UMR 9002 Institute of Human Genetics Montpellier France
| |
Collapse
|
13
|
Sarmiento Varón L, De Rosa J, Rodriguez R, Fernández PM, Billordo LA, Baz P, Beccaglia G, Spada N, Mendoza FT, Barberis CM, Vay C, Arabolaza ME, Paoli B, Arana EI. Role of Tonsillar Chronic Inflammation and Commensal Bacteria in the Pathogenesis of Pediatric OSA. Front Immunol 2021; 12:648064. [PMID: 33995367 PMCID: PMC8116894 DOI: 10.3389/fimmu.2021.648064] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2020] [Accepted: 04/06/2021] [Indexed: 01/01/2023] Open
Abstract
Immune responses at the boundary between the host and the world beyond are complex and mucosal tissue homeostasis relies on them. Obstructive sleep apnea (OSA) is a syndrome suffered by children with hypertrophied tonsils. We have previously demonstrated that these tonsils present a defective regulatory B cell (Breg) compartment. Here, we extend those findings by uncovering the crucial role of resident pro-inflammatory B and T cells in sustaining tonsillar hypertrophy and hyperplasia by producing TNFα and IL17, respectively, in ex vivo cultures. Additionally, we detected prominent levels of expression of CD1d by tonsillar stratified as well as reticular epithelium, which have not previously been reported. Furthermore, we evidenced the hypertrophy of germinal centers (GC) and the general hyperplasia of B lymphocytes within the tissue and the lumen of the crypts. Of note, such B cells resulted mainly (IgG/IgM)+ cells, with some IgA+ cells located marginally in the follicles. Finally, by combining bacterial culture from the tonsillar core and subsequent identification of the respective isolates, we determined the most prevalent species within the cohort of OSA patients. Although the isolated species are considered normal oropharyngeal commensals in children, we confirmed their capacity to breach the epithelial barrier. Our work sheds light on the pathological mechanism underlying OSA, highlighting the relevance taken by the host immune system when defining infection versus colonization, and opening alternatives of treatment.
Collapse
Affiliation(s)
- Lindybeth Sarmiento Varón
- Institute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Buenos Aires, Argentina
| | - Javier De Rosa
- Institute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Buenos Aires, Argentina
| | - Raquel Rodriguez
- Institute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Buenos Aires, Argentina.,Allergy and Immunology Division, Clinical Hospital 'José de San Martín', UBA, Buenos Aires, Argentina
| | - Pablo M Fernández
- Institute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Buenos Aires, Argentina.,Department of Immunology, School of Medicine, UBA, Buenos Aires, Argentina
| | - L Ariel Billordo
- Institute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Buenos Aires, Argentina
| | - Plácida Baz
- Institute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Buenos Aires, Argentina
| | - Gladys Beccaglia
- Department of Pathology, Clinical Hospital 'José de San Martín', Buenos Aires, Argentina
| | - Nicolás Spada
- Department of Pathology, Clinical Hospital 'José de San Martín', Buenos Aires, Argentina
| | - F Tatiana Mendoza
- Department of Clinical Biochemistry and Bacteriology, School of Pharmacy and Biochemistry, Clinical Hospital 'Jose de San Martín', UBA, Buenos Aires, Argentina
| | - Claudia M Barberis
- Department of Clinical Biochemistry and Bacteriology, School of Pharmacy and Biochemistry, Clinical Hospital 'Jose de San Martín', UBA, Buenos Aires, Argentina
| | - Carlos Vay
- Department of Clinical Biochemistry and Bacteriology, School of Pharmacy and Biochemistry, Clinical Hospital 'Jose de San Martín', UBA, Buenos Aires, Argentina
| | - M Elena Arabolaza
- Pediatric Otolaryngology Division, Clinical Hospital 'José de San Martín', Buenos Aires, Argentina
| | - Bibiana Paoli
- Pediatric Otolaryngology Division, Clinical Hospital 'José de San Martín', Buenos Aires, Argentina
| | - Eloísa I Arana
- Institute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Buenos Aires, Argentina.,Department of Immunology, School of Medicine, UBA, Buenos Aires, Argentina
| |
Collapse
|
14
|
Roso-Bas F, Alonso-Llobregat MD, Bento L, Sanchez-Gonzalez B, Herraez I, Garcia-Dilla P, Vallespir C, Rado F, Rodriguez R, Garcia-Pallarols F, Aguirre I, Bargay J, Sampol A, Salar A, Gutierrez A. Analysis of Personality Traits in Patients with Hodgkin Lymphoma. J Clin Med 2021; 10:jcm10081631. [PMID: 33921383 PMCID: PMC8069925 DOI: 10.3390/jcm10081631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2021] [Revised: 03/22/2021] [Accepted: 04/08/2021] [Indexed: 11/16/2022] Open
Abstract
Hodgkin lymphoma (HL) is a highly-curable malignancy mostly affecting young people. As far as we know, there is no published study that has analyzed personality profiles in HL nor their potential role in lymphomagenesis, natural history, or response to treatment. We aim to explore the personality traits of HL patients, as well as the prevalence of mental disorders and suicide ideas. We retrospectively identified all alive HL patients from three centers (Son Espases and Son Llatzer University Hospitals and Hospital del Mar of Barcelona) for using NEO Five-Factor Inventory (NEO-FFI) and Personality Inventory for DSM-5 Brief Form. Patients with HL showed significantly higher neuroticism scores and lower conscientiousness, extraversion, and openness. Considering maladaptive personality traits, HL patients showed higher levels of detachment and psychoticism. All of these translated into the fact that HL patients showed more than double the prevalence of mental illnesses (41%) and more than triple the prevalence of suicidal ideation or attempts than the general population (15 and 6%, respectively). An exploratory analysis of biomarkers associated with HL personality traits showed that higher scores of neuroticism correlated with more elevated erythrocyte sedimentation rate (ESR) and red cell distribution width (RDW), suggesting a potential link between neuroticism and proinflammatory activity in HL.
Collapse
Affiliation(s)
- Fatima Roso-Bas
- Clinical Practice and Biology of the Hematological Malignancies Research Group, IdISBa, Son Espases University Hospital, 07120 Palma de Mallorca, Spain; (F.R.-B.); (M.D.A.-L.); (L.B.); (I.H.); (J.B.); (A.S.)
| | - Maria Dolores Alonso-Llobregat
- Clinical Practice and Biology of the Hematological Malignancies Research Group, IdISBa, Son Espases University Hospital, 07120 Palma de Mallorca, Spain; (F.R.-B.); (M.D.A.-L.); (L.B.); (I.H.); (J.B.); (A.S.)
| | - Leyre Bento
- Clinical Practice and Biology of the Hematological Malignancies Research Group, IdISBa, Son Espases University Hospital, 07120 Palma de Mallorca, Spain; (F.R.-B.); (M.D.A.-L.); (L.B.); (I.H.); (J.B.); (A.S.)
- Unit of Lymphoma, Department of Hematology, Son Espases University Hospital, 07120 Palma de Mallorca, Spain
| | - Blanca Sanchez-Gonzalez
- Department of Hematology, Hospital del Mar, 08003 Barcelona, Spain; (B.S.-G.); (P.G.-D.); (F.G.-P.); (A.S.)
- IMIM, Hospital del Mar Research Institute, 08003 Barcelona, Spain
| | - Ines Herraez
- Clinical Practice and Biology of the Hematological Malignancies Research Group, IdISBa, Son Espases University Hospital, 07120 Palma de Mallorca, Spain; (F.R.-B.); (M.D.A.-L.); (L.B.); (I.H.); (J.B.); (A.S.)
- Department of Hematology. Son Llatzer University Hospital, 07120 Palma de Mallorca, Spain
| | - Pilar Garcia-Dilla
- Department of Hematology, Hospital del Mar, 08003 Barcelona, Spain; (B.S.-G.); (P.G.-D.); (F.G.-P.); (A.S.)
| | - Catalina Vallespir
- Service of Psychiatry, Son Espases University Hospital, 07120 Palma de Mallorca, Spain; (C.V.); (F.R.); (I.A.)
| | - Francesca Rado
- Service of Psychiatry, Son Espases University Hospital, 07120 Palma de Mallorca, Spain; (C.V.); (F.R.); (I.A.)
| | - Raquel Rodriguez
- Psychosocial Support Team, Son Llatzer University Hospital, 07198 Palma de Mallorca, Spain;
| | - Francesc Garcia-Pallarols
- Department of Hematology, Hospital del Mar, 08003 Barcelona, Spain; (B.S.-G.); (P.G.-D.); (F.G.-P.); (A.S.)
| | - Irache Aguirre
- Service of Psychiatry, Son Espases University Hospital, 07120 Palma de Mallorca, Spain; (C.V.); (F.R.); (I.A.)
| | - Joan Bargay
- Clinical Practice and Biology of the Hematological Malignancies Research Group, IdISBa, Son Espases University Hospital, 07120 Palma de Mallorca, Spain; (F.R.-B.); (M.D.A.-L.); (L.B.); (I.H.); (J.B.); (A.S.)
- Department of Hematology. Son Llatzer University Hospital, 07120 Palma de Mallorca, Spain
| | - Antonia Sampol
- Clinical Practice and Biology of the Hematological Malignancies Research Group, IdISBa, Son Espases University Hospital, 07120 Palma de Mallorca, Spain; (F.R.-B.); (M.D.A.-L.); (L.B.); (I.H.); (J.B.); (A.S.)
| | - Antonio Salar
- Department of Hematology, Hospital del Mar, 08003 Barcelona, Spain; (B.S.-G.); (P.G.-D.); (F.G.-P.); (A.S.)
- IMIM, Hospital del Mar Research Institute, 08003 Barcelona, Spain
| | - Antonio Gutierrez
- Clinical Practice and Biology of the Hematological Malignancies Research Group, IdISBa, Son Espases University Hospital, 07120 Palma de Mallorca, Spain; (F.R.-B.); (M.D.A.-L.); (L.B.); (I.H.); (J.B.); (A.S.)
- Unit of Lymphoma, Department of Hematology, Son Espases University Hospital, 07120 Palma de Mallorca, Spain
- Correspondence: ; Tel.: +34-(8)-7120-5000 (ext. 65115)
| |
Collapse
|
15
|
Ibrahim KM, Schommer JC, Morisky DE, Rodriguez R, Gaither C, Snyder M. The Association between Medication Experiences and Beliefs and Low Medication Adherence in Patients with Chronic Disease from Two Different Societies: The USA and the Sultanate of Oman. Pharmacy (Basel) 2021; 9:pharmacy9010031. [PMID: 33546425 PMCID: PMC7931077 DOI: 10.3390/pharmacy9010031] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2020] [Revised: 01/29/2021] [Accepted: 01/31/2021] [Indexed: 12/03/2022] Open
Abstract
This cross-sectional study aimed to describe the association between medication experiences and beliefs and self-reported medication adherence in patients with chronic diseases in two different samples from two different societies: the USA and the Sultanate of Oman. The Morisky Medication Adherence Score (MMAS-8) questionnaire was used to measure medication adherence. Three items (statements) were used for measuring medication experiences and beliefs variable on a four-point Likert scale adapted from the 2015 National Consumer Survey of the Medication Experience and Pharmacists’ Role (NCSME&PR). In the U.S., quantitative secondary data analysis of 13,731 participants was conducted using the 2015 NCSME&PR, a self-administered online survey coordinated by Qualtrics Panels between 28 April 2015 and 22 June 2015. The same variables were translated into Arabic, with studies conducted at the Royal Court Medical Center in Oman, and data from 714 participants were collected between 16 June 2019 and 16 August 2019. Data were analyzed using IMB/SPSS version 24.0 software. Chi-square analysis and descriptive statistics were used. The results showed that the low adherence rates for medication (MMAS-8 < 6) were 56% and 52% in Omani and U.S. groups, respectively. Approximately 90% of the U.S. and Omani participants believed that “medicines are a life-saver”; however, medication adherence was higher in Oman (30%) than in the United States (9%) for these participants. In total, 60% of the U.S. and 29% of Omani participants believed that “medicines are a burden”; however, about 60–65% of participants in both countries were in the low medication adherence group. Additionally, 63% of the U.S. and 83% of the Omani participants disagreed that “medicines do more harm than good”; however, medication adherence in the U.S. (15%) was higher than in Oman (8%). In conclusion, a decrease in low medication adherence was observed with positive medication experiences and beliefs. However, the impacts of medication experiences and beliefs on low medication adherence rates were different from one population to another. The “medication burden” statement resulted in the highest percentage of difference in terms of low medication adherence rates between those who agree and those who disagree in the U.S. group (20%), whereas the “medicines are a life-saver” statement resulted in a greater difference in the Omani group (30%). Proper communication between patients and healthcare providers based on the patient’s medication experiences and beliefs will substantially improve medication adherence.
Collapse
Affiliation(s)
- Kamla M. Ibrahim
- Department of Pharmaceutical Care & Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA; (J.C.S.); (R.R.); (C.G.)
- Correspondence:
| | - Jon C. Schommer
- Department of Pharmaceutical Care & Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA; (J.C.S.); (R.R.); (C.G.)
| | - Donald E. Morisky
- Community Health Sciences, Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA;
| | - Raquel Rodriguez
- Department of Pharmaceutical Care & Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA; (J.C.S.); (R.R.); (C.G.)
| | - Caroline Gaither
- Department of Pharmaceutical Care & Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA; (J.C.S.); (R.R.); (C.G.)
| | - Mark Snyder
- Center for the Study of the Individual and Society, Department of Psychology, College of Liberal Arts, University of Minnesota, Minneapolis, MN 55455, USA;
| |
Collapse
|
16
|
Ibilibor C, Wang H, Kaushik D, Rodriguez R. Use of an Open-Source Software to Examine Low Skeletal Muscle Mass in Penile Cancer Patients: A Cross-Sectional Study. JAR Life 2021; 10:45-49. [PMID: 36923513 PMCID: PMC10002885 DOI: 10.14283/jarlife.2021.8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/04/2021] [Accepted: 06/13/2021] [Indexed: 11/11/2022]
Abstract
Purpose Low skeletal muscle mass determined radiographically has emerged as an important prognostic marker in penile cancer patients but may be unrecognized in obese patients with a high comorbid disease burden. Moreover, publicly available software for image segmentation are limited. Thus, we describe the prevalence of radiographically low skeletal muscle mass in an obese penile cancer cohort, using an open-source software and examine its association with comorbid disease burden. Methods This is a cross-sectional study, utilizing retrospective data from patients diagnosed with penile squamous cell carcinoma between October 2009 and December 2019. Available digital files of perioperative computerized tomography were analyzed, using CoreSlicer, an open-source image segmentation software. The correlation between radiographically low skeletal muscle mass, defined as a skeletal muscle index (SMI) less than 55 cm2/m2 and a Charlson Comorbidity Index (CCI) greater than 4 was examined, using logistic and linear regression. Results Forty two of 59 patients had available digital files. Median SMI and body mass index (BMI) were 54.6cm2/m2 and 30.2kg/m2 respectively for the entire cohort. Of included patients, 54% had radiographically low skeletal muscle mass and a median BMI of 28.9 kg/m2. Radiographically low skeletal muscle mass was associated with a CCI greater than 4 on univariable and multivariable logistic regression with odds ratios of 4.85 (p = 0.041) and 7.32 (p = 0.033), respectively. When CCI was treated as a continuous variable on linear regression, the association between radiographically low skeletal muscle mass and CCI was positive, but not statistically significant with an estimated effect of 1.29 (p = 0.1) and 1.27 (p = 0.152) on univariable and multivariable analysis, respectively. Conclusion Our data demonstrate that low skeletal muscle mass can be readily assessed with CoreSlicer and is associated with a CCI greater than 4 in obese penile cancer patients.
Collapse
Affiliation(s)
- C Ibilibor
- Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
| | - H Wang
- Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
| | - D Kaushik
- Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
| | - R Rodriguez
- Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
| |
Collapse
|
17
|
Alvarez J, Godoy P, Plans-Rubio P, Camps N, Carol M, Carmona G, Solano R, Rius C, Minguell S, Barrabeig I, Sala-Farré MR, Rodriguez R, Garcia-Cenoz M, Muñoz-Almagro C, Dominguez A. Azithromycin to Prevent Pertussis in Household Contacts, Catalonia and Navarre, Spain, 2012-2013. Emerg Infect Dis 2020; 26:2678-2684. [PMID: 33079034 PMCID: PMC7588542 DOI: 10.3201/eid2611.181418] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
We retrospectively assessed the effectiveness of azithromycin in preventing transmission of pertussis to a patient's household contacts. We also considered the duration between symptom onset in the primary patient and azithromycin administration. We categorized contacts into 4 groups: those treated within <7 days, 8-14 days, 15-21 days, and >21 days after illness onset in the primary patient. We studied 476 primary index patients and their 1,975 household contacts, of whom 4.5% were later identified as having pertussis. When contacts started chemoprophylaxis within <21 days after the primary patient's symptom onset, the treatment was 43.9% effective. Chemoprophylaxis started >14 days after primary patient's symptom onset was less effective. We recommend that contacts of persons with pertussis begin chemoprophylaxis within <14 days after primary patient's symptom onset.
Collapse
|
18
|
Caballero E, Gutierrez R, Castenada J, Schmitt E, Torres-Cacho N, Diaz A, Rodriguez R. 225 Impact of Anti-immigrant Political Climate on Latinx Families and Children’s Utilization of Health Care Services. Ann Emerg Med 2020. [DOI: 10.1016/j.annemergmed.2020.09.238] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
19
|
Vo T, Blackwell T, Kats A, Langsetmo L, Taylor B, Schousboe J, Redline S, Stone K, Smagula S, Chu H, Rodriguez R, Schommer J, Carlson A, Ensrud K. 0388 Predictors of Incident Reduced Sleep Efficiency in Community-Dwelling Older Women. Sleep 2020. [DOI: 10.1093/sleep/zsaa056.385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
There is a paucity of longitudinal studies with sleep efficiency (SE) as an outcome measure. Our objective was to examine potential risk factors for incident reduced SE among community-dwelling women in late life.
Methods
We studied 700 women (mean age 82.5 [SD=3.0] years) with a SE ≥70% at the Year 16 (2002-04) visit of the Study of Osteoporotic Fractures with a follow-up measure of SE at the Year 20 (2006-08) visit. SE (percentage of time sleeping while in bed) at both visits was measured using a wrist actigraph with data collected for an average of four 24-hour periods. Women were classified as having incident reduced SE if they had SE <70% at Year 20. Logistic regression was used to estimate the associations between potential risk factors (demographics, lifestyle, use of medications, self-reported medical conditions, functional impairment, frailty, mental and physical health) at Year 16 and reduced SE at Year 20. The association of each candidate risk factor with reduced SE at Year 20 was examined in models adjusted for age, clinical site and continuous SE at Year 16. Candidate risk factors with Benjamin Hochberg false-discovery rate q-values <0.10 were included in a final multivariate model.
Results
Among the 700 eligible women, 62 (8.9%) developed incident reduced SE between the Year 16 and Year 20 visits. After adjusting for age, site and baseline SE, antidepressant use [OR=3.06; 95% CI: 1.50-6.25], benzodiazepine use [OR=2.97; 95% CI: 1.30-6.80] and the presence of hypertension [OR=2.83; 95% CI: 1.47-5.45] at Year 16 were independently associated with a higher odds of having reduced SE at follow-up.
Conclusion
These findings suggest that antidepressant use, benzodiazepine use and hypertension are risk factors or markers for the development of reduced sleep efficiency in older women. Future studies are warranted to examine the underlying mechanisms for these associations.
Support
The Study of Osteoporotic Fractures (SOF) is supported by National Institutes of Health funding. The National Institute on Aging (NIA) provides support under the following grant numbers: R01 AG005407, R01 AR35582, R01 AR35583, R01 AR35584, R01 AG005394, R01 AG027574, and R01 AG027576.
Collapse
Affiliation(s)
- T Vo
- University of Minnesota, Minneapolis, MN
| | - T Blackwell
- California Pacific Medical Center Research Institute, San Francisco, CA
| | - A Kats
- University of Minnesota, Minneapolis, MN
| | | | - B Taylor
- University of Minnesota, Minneapolis, MN
- Minneapolis VA Health Care System, Minneapolis, MN
| | - J Schousboe
- University of Minnesota, Minneapolis, MN
- HealthPartners Institute, Bloomington, MN
| | - S Redline
- Brigham and Women’s Hospital, Boston, MA
| | - K Stone
- California Pacific Medical Center Research Institute, San Francisco, CA
| | - S Smagula
- University of Pittsburgh, Pittsburgh, PA
| | - H Chu
- University of Minnesota, Minneapolis, MN
| | | | - J Schommer
- University of Minnesota, Minneapolis, MN
| | - A Carlson
- University of Minnesota, Minneapolis, MN
| | - K Ensrud
- University of Minnesota, Minneapolis, MN
- Minneapolis VA Health Care System, Minneapolis, MN
| |
Collapse
|
20
|
Rodriguez R, Bekas DG, Flórez S, Kosarli M, Paipetis AS. Development of self-contained microcapsules for optimised catalyst position in self-healing materials. POLYMER 2020. [DOI: 10.1016/j.polymer.2019.122084] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
21
|
Vos S, Kooyman C, Feudo D, Goliak KL, Kieser M, Legg J, Parent-Stevens L, Walker PC, Rodriguez R. When Experiential Education Intersects with Learning Disabilities. Am J Pharm Educ 2019; 83:7468. [PMID: 31831910 PMCID: PMC6900816 DOI: 10.5688/ajpe7468] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Affiliation(s)
- Susan Vos
- The University of Iowa College of Pharmacy, Iowa City, Iowa
| | - Chase Kooyman
- The University of Iowa College of Pharmacy, Iowa City, Iowa
| | - Donna Feudo
- Rutgers Ernst Mario School of Pharmacy, Piscataway, New Jersey
| | - Kristen L Goliak
- University of Illinois at Chicago, College of Pharmacy, Chicago, Illinois
| | - Mara Kieser
- University of Wisconsin School of Pharmacy, Madison, Wisconsin
| | - Julie Legg
- The Ohio State University, Columbus, Ohio
| | | | - Paul C Walker
- University of Michigan College of Pharmacy, Ann Arbor, Michigan
| | - Raquel Rodriguez
- University of Minnesota College of Pharmacy, Minneapolis, Minneapolis
| |
Collapse
|
22
|
Reneses B, Ochoa S, Vila-Badia R, Lopez-Micó C, Fernández Garcia-Andrade R, Rodriguez R, Argudo I, Carrascosa C, Thornicroft G. Validation of the spanish version of the discrimination and stigma scale (DISC 12). Actas Esp Psiquiatr 2019; 47:137-148. [PMID: 31461153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 07/01/2019] [Accepted: 07/01/2019] [Indexed: 06/10/2023]
Abstract
AIMS The "Discrimination and Stigma Scale" (DISC) was the first instrument specifically designed to evaluate reported experiences of discrimination by people with mental disorders. This study aims to validate DISC-12 version in Spanish population with Schizophrenia and, as specific objectives, to do the external validation with the Self-Stigma Questionnaire (SSQ) scale and Link PDD scale and to validate their internal consistency, temporal and inter-rater reliability. METHODS 86 individuals with schizophrenia were interviewed at two time points (between one to two weeks) by two raters. Additionally to assess their sociodemographic and clinical characteristics, following scales were administered: DISC 12, SSQ, PDD, Social Functioning Scale (SFS) and Global Assessment of Function (GAF). RESULTS Internal consistency as a whole results a Cronbach a between 0.741 and 0.850. Subscales "Unfair treatmen" and "Positive treatment" have a Cronbach a higher than 0.79, but the both subscales "Stopping Self" and "Overcoming stigma" do not have in themselves an adequate consistency. Test-retest reliability shows that four subscales have values higher than 0.67. Inter-rater reliability assessment result that 21 items score values above 0.8, 10 between 0.6-0.8 and one lower than 0.6. DISC-12 was significantly related with the second factor of the PDD (self-stigma) and SSQ. CONCLUSIONS The Spanish version of the DISC 12 scale is valid, has good internal consistency, is reliable both in terms of test-retest and inter-rater reliability and has good convergent validity with the SSQ and PDD, and the "Unfair treatment" and "Positive Treatment" subscales were the most robust of the four subscales.
Collapse
Affiliation(s)
- Blanca Reneses
- Instituto de Psiquiatría y Salud Mental. Hospital Clínico San Carlos. Madrid. España Insituto de Investigación Sanitaria, IdISSC. Hospital Clínico San Carlos. Madrid. España Universidad Complutense. Madrid. España
| | | | | | - Cristina Lopez-Micó
- Instituto de Psiquiatría y Salud Mental. Hospital Clínico San Carlos. Madrid. España
| | - Rafael Fernández Garcia-Andrade
- Instituto de Psiquiatría y Salud Mental. Hospital Clínico San Carlos. Madrid. España Insituto de Investigación Sanitaria, IdISSC. Hospital Clínico San Carlos. Madrid. España Universidad Complutense. Madrid. España
| | - Raquel Rodriguez
- Instituto de Psiquiatría y Salud Mental. Hospital Clínico San Carlos. Madrid. España
| | - Isabel Argudo
- Instituto de Psiquiatría y Salud Mental. Hospital Clínico San Carlos. Madrid. España Insituto de Investigación Sanitaria, IdISSC. Hospital Clínico San Carlos. Madrid. España
| | - Carmen Carrascosa
- Instituto de Psiquiatría y Salud Mental. Hospital Clínico San Carlos. Madrid. España
| | - Graham Thornicroft
- Centre for Global Mental Health & Centre for Implementation Science. Health Service and Population Research Department. Institute of Psychiatry, Psychology and Neuroscience. King's College U.K
| |
Collapse
|
23
|
Smith MS, Cash B, Konda V, Trindade AJ, Gordon S, DeMeester S, Joshi V, Diehl D, Ganguly E, Mashimo H, Singh S, Jobe B, McKinley M, Wallace M, Komatsu Y, Thakkar S, Schnoll-Sussman F, Sharaiha R, Kahaleh M, Tarnasky P, Wolfsen H, Hawes R, Lipham J, Khara H, Pleskow D, Navaneethan U, Kedia P, Hasan M, Sethi A, Samarasena J, Siddiqui UD, Gress F, Rodriguez R, Lee C, Gonda T, Waxman I, Hyder S, Poneros J, Sharzehi K, Di Palma JA, Sejpal DV, Oh D, Hagen J, Rothstein R, Sawhney M, Berzin T, Malik Z, Chang K. Volumetric laser endomicroscopy and its application to Barrett's esophagus: results from a 1,000 patient registry. Dis Esophagus 2019; 32:5481776. [PMID: 31037293 PMCID: PMC6853704 DOI: 10.1093/dote/doz029] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/22/2018] [Revised: 02/08/2019] [Indexed: 12/11/2022]
Abstract
Volumetric laser endomicroscopy (VLE) uses optical coherence tomography (OCT) for real-time, microscopic cross-sectional imaging. A US-based multi-center registry was constructed to prospectively collect data on patients undergoing upper endoscopy during which a VLE scan was performed. The objective of this registry was to determine usage patterns of VLE in clinical practice and to estimate quantitative and qualitative performance metrics as they are applied to Barrett's esophagus (BE) management. All procedures utilized the NvisionVLE Imaging System (NinePoint Medical, Bedford, MA) which was used by investigators to identify the tissue types present, along with focal areas of concern. Following the VLE procedure, investigators were asked to answer six key questions regarding how VLE impacted each case. Statistical analyses including neoplasia diagnostic yield improvement using VLE was performed. One thousand patients were enrolled across 18 US trial sites from August 2014 through April 2016. In patients with previously diagnosed or suspected BE (894/1000), investigators used VLE and identified areas of concern not seen on white light endoscopy (WLE) in 59% of the procedures. VLE imaging also guided tissue acquisition and treatment in 71% and 54% of procedures, respectively. VLE as an adjunct modality improved the neoplasia diagnostic yield by 55% beyond the standard of care practice. In patients with no prior history of therapy, and without visual findings from other technologies, VLE-guided tissue acquisition increased neoplasia detection over random biopsies by 700%. Registry investigators reported that VLE improved the BE management process when used as an adjunct tissue acquisition and treatment guidance tool. The ability of VLE to image large segments of the esophagus with microscopic cross-sectional detail may provide additional benefits including higher yield biopsies and more efficient tissue acquisition. Clinicaltrials.gov NCT02215291.
Collapse
Affiliation(s)
- M S Smith
- Mount Sinai West & Mount Sinai St. Luke's Hospitals, New York, New York,Address correspondence to: Michael S. Smith, M.D., M.B.A., Chief of Gastroenterology and Hepatology, Mount Sinai West & Mount Sinai St. Luke's Hospitals, Ambulatory Care Center, Floor 13, 440 W. 114th Street, New York, NY 10025, USA.
| | - B Cash
- University of Texas Health Science Center at Houston, Houston, Texas
| | - V Konda
- Baylor University Medical Center, Dallas, Texas
| | - A J Trindade
- Zucker School of Medicine at Hofstra/Northwell, Northwell Health System Manhasset, New York
| | - S Gordon
- Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
| | | | - V Joshi
- University Medical Center at LSU, New Orleans, Louisiana
| | - D Diehl
- Geisinger Medical Center, Danville, Pennsylvania
| | - E Ganguly
- University of Vermont Medical Center, Burlington, Vermont
| | - H Mashimo
- VA Boston Health Care System, Boston, Massachusetts
| | - S Singh
- VA Boston Health Care System, Boston, Massachusetts
| | - B Jobe
- Allegheny Health Network, Pittsburgh, Pennsylvania
| | - M McKinley
- Zucker School of Medicine at Hofstra/Northwell, Northwell Health System Manhasset, New York,ProHEALTHcare Associates, Lake Success, New York, New York
| | | | - Y Komatsu
- Allegheny Health Network, Pittsburgh, Pennsylvania
| | - S Thakkar
- Allegheny Health Network, Pittsburgh, Pennsylvania
| | | | - R Sharaiha
- Weill Cornell Medicine, New York, New York
| | - M Kahaleh
- Robert Wood Johnson University Hospital, New Brunswick, New Jersey
| | | | | | - R Hawes
- Florida Hospital, Orlando, Florida
| | - J Lipham
- University of Southern California, Keck School of Medicine, Los Angeles, California
| | - H Khara
- Geisinger Medical Center, Danville, Pennsylvania
| | - D Pleskow
- Beth Israel Deaconess Medical Center, Boston, Massachusetts
| | | | - P Kedia
- Methodist Health System, Dallas, Texas
| | - M Hasan
- Florida Hospital, Orlando, Florida
| | - A Sethi
- Columbia University Medical Center, New York, New York
| | | | | | - F Gress
- Columbia University Medical Center, New York, New York
| | - R Rodriguez
- University of South Alabama, Mobile, Alabama
| | - C Lee
- Zucker School of Medicine at Hofstra/Northwell, Northwell Health System Manhasset, New York
| | - T Gonda
- Columbia University Medical Center, New York, New York
| | - I Waxman
- Chicago Medicine, Chicago, Illinois
| | - S Hyder
- Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
| | - J Poneros
- Columbia University Medical Center, New York, New York
| | - K Sharzehi
- Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania
| | - J A Di Palma
- University of Texas Health Science Center at Houston, Houston, Texas
| | - D V Sejpal
- Zucker School of Medicine at Hofstra/Northwell, Northwell Health System Manhasset, New York
| | - D Oh
- University of Southern California, Keck School of Medicine, Los Angeles, California
| | - J Hagen
- University of Southern California, Keck School of Medicine, Los Angeles, California
| | - R Rothstein
- Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
| | - M Sawhney
- Beth Israel Deaconess Medical Center, Boston, Massachusetts
| | - T Berzin
- Beth Israel Deaconess Medical Center, Boston, Massachusetts
| | - Z Malik
- Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania
| | - K Chang
- UC Irvine Medical Center, Irvine, California
| |
Collapse
|
24
|
Madrona AP, Cabañas J, Rull R, Rodriguez R, Hernández-Gil J, Gil-Olarte A, Rioja M, Vidal-Sicart S. Isotopic vs. ferromagnetic tracers in sentinel node biopsy for cutaneous melanoma: preliminary results of IMINEM study. Eur J Surg Oncol 2019. [DOI: 10.1016/j.ejso.2018.10.462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
25
|
|
26
|
Porter J, Frye K, Rodriguez R, Velez Arias M, VanDenburg G. 23 Impact of Implementing a Direct Bedding Process on Emergency Department Throughput and Leaving Without Being Seen Rates. Ann Emerg Med 2018. [DOI: 10.1016/j.annemergmed.2018.08.028] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
27
|
Bizimungu R, Alvarez S, Rodriguez R. 290 Thoracic Spine Fracture in the Pan Scan Era. Ann Emerg Med 2018. [DOI: 10.1016/j.annemergmed.2018.08.295] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
28
|
García AJM, Molina Méndez F, Lespron Robles M, Piedracruz Ramos L, Beltran Ochoa J, Martinez J, Rodriguez R, Lepe Mancilla J. Frailty assessment versus conventional risk scores for predicting 1 year outcome after TAVR. J Cardiothorac Vasc Anesth 2018. [DOI: 10.1053/j.jvca.2018.08.152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
29
|
Menendez S, Martinez-Cruzado L, Rey-Vazquez V, Estupiñan O, Rodriguez R. PO-273 Evaluation of the role of SOX2 as cancer stem cell marker in sarcomas. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
30
|
Siso C, Esgueva A, Rodriguez R, Espinosa M, Córdoba O, Rubio I. Her2 positive and triple negative breast cancer patients with clinically negative nodes at diagnosis and breast pathologic complete response may spare axillary surgery after neoadjuvant treatment. Eur J Cancer 2018. [DOI: 10.1016/s0959-8049(18)30288-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
31
|
Rubio IT, Rodriguez R, Esgueva-Colmenarejo A, Suarez M, Espinosa-Bravo M, Siso C, Cordoba O, Alvarado S, Volders J, Van Den Tol P. Abstract P5-22-10: Intraoperative ultrasound guided surgery after neoadjuvant treatment in breast cancer improves patient´s quality of life. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p5-22-10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Intraoperative ultrasound guided surgery (IOUS) has shown not only to improve surgical outcomes by achieving higher rates of negative margins and reducing the need for re-excisions, but also showing better cosmetic results and patient's satisfaction in the adjuvant setting. After neoadjuvant treatments (NAT) we have shown that IOUS lowers the volume of resection in patients with pathologic complete response or minimal microscopic disease after NAT without compromising margins and local recurrences when compared to wire localization techniques (WL) The aim of this study was to determine if IOUS after NAT contributes to improve cosmetic outcomes and quality of life (QOL) when compared with WL.
Material and Methods. The pilot study enrolled patients treated with NAT who underwent breast-conserving surgery (BCS) between July 2008 and December 2012. On the follow up visit, cosmetic outcomes were assessed by the patient and surgeon on a 4 point Likert scale, by the Breast Cancer Conservative Treatment cosmetic results (BCCT.core) software, and by an independent panel. QOL was assessed using cancer-specific (EORTC QLQ-C30 and EORTC QLQ-B23) questionnaires.
Results. The study investigated 113 patients: 81 (71.6 %) in the IOUS group and 32 (28.3 %) in the WL group. The patient and tumor characteristics were comparable between the two groups. Mean follow up was 64 months (range, 12-90) in the WL group while 41 months (range, 18-107) in the IOUS group.
Cosmetic outcomes reported by the patient showed a tendency (p=0.07) for better results in the IOUS group. Patient reported cosmetic outcomes and the independent panel cosmetic evaluation significantly correlated with lumpectomy volume excised (p= 0.04, p = 0.02 respectively). The BCCT.core did not correlate with volume of tissue excised (p < 0.14). IOUS achieved better cosmetic outcomes compared to WL, with excellent outcomes of 30% and 19% respectively, although poor cosmetic outcomes were 3% and 0% respectively. Correlation between patients and surgeons evaluation regarding cosmetic outcomes and satisfaction was low (0.38 and 0.40 respectively). A comparison of the QOL scores of 113 patients showed a significantly better global health status (p = 0.03), better emotional and role function (p = 0.004), for patients with IOUS compared to WL patients.
Conclusions. This is the first study to show that breast volume excised significantly correlates with cosmetic outcomes in the neoadjuvant setting. These results suggest that IOUS after NAT contributes to a better quality of life and may influence cosmetic outcomes in breast cancer patients. Patient reported outcomes should be included in the quality assessment in breast surgery as the correlation with surgeons' evaluation is low.
Citation Format: Rubio IT, Rodriguez R, Esgueva-Colmenarejo A, Suarez M, Espinosa-Bravo M, Siso C, Cordoba O, Alvarado S, Volders J, Van Den Tol P. Intraoperative ultrasound guided surgery after neoadjuvant treatment in breast cancer improves patient´s quality of life [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P5-22-10.
Collapse
Affiliation(s)
- IT Rubio
- Hospital Univeristario VAll d¨Hebron, Barcelona, Spain; VU University Medical Center, Amsterdam, Netherlands
| | - R Rodriguez
- Hospital Univeristario VAll d¨Hebron, Barcelona, Spain; VU University Medical Center, Amsterdam, Netherlands
| | - A Esgueva-Colmenarejo
- Hospital Univeristario VAll d¨Hebron, Barcelona, Spain; VU University Medical Center, Amsterdam, Netherlands
| | - M Suarez
- Hospital Univeristario VAll d¨Hebron, Barcelona, Spain; VU University Medical Center, Amsterdam, Netherlands
| | - M Espinosa-Bravo
- Hospital Univeristario VAll d¨Hebron, Barcelona, Spain; VU University Medical Center, Amsterdam, Netherlands
| | - C Siso
- Hospital Univeristario VAll d¨Hebron, Barcelona, Spain; VU University Medical Center, Amsterdam, Netherlands
| | - O Cordoba
- Hospital Univeristario VAll d¨Hebron, Barcelona, Spain; VU University Medical Center, Amsterdam, Netherlands
| | - S Alvarado
- Hospital Univeristario VAll d¨Hebron, Barcelona, Spain; VU University Medical Center, Amsterdam, Netherlands
| | - J Volders
- Hospital Univeristario VAll d¨Hebron, Barcelona, Spain; VU University Medical Center, Amsterdam, Netherlands
| | - P Van Den Tol
- Hospital Univeristario VAll d¨Hebron, Barcelona, Spain; VU University Medical Center, Amsterdam, Netherlands
| |
Collapse
|
32
|
Higginson DP, Khiar B, Revet G, Béard J, Blecher M, Borghesi M, Burdonov K, Chen SN, Filippov E, Khaghani D, Naughton K, Pépin H, Pikuz S, Portugall O, Riconda C, Riquier R, Rodriguez R, Ryazantsev SN, Skobelev IY, Soloviev A, Starodubtsev M, Vinci T, Willi O, Ciardi A, Fuchs J. Enhancement of Quasistationary Shocks and Heating via Temporal Staging in a Magnetized Laser-Plasma Jet. Phys Rev Lett 2017; 119:255002. [PMID: 29303310 DOI: 10.1103/physrevlett.119.255002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/03/2017] [Indexed: 06/07/2023]
Abstract
We investigate the formation of a laser-produced magnetized jet under conditions of a varying mass ejection rate and a varying divergence of the ejected plasma flow. This is done by irradiating a solid target placed in a 20 T magnetic field with, first, a collinear precursor laser pulse (10^{12} W/cm^{2}) and, then, a main pulse (10^{13} W/cm^{2}) arriving 9-19 ns later. Varying the time delay between the two pulses is found to control the divergence of the expanding plasma, which is shown to increase the strength of and heating in the conical shock that is responsible for jet collimation. These results show that plasma collimation due to shocks against a strong magnetic field can lead to stable, astrophysically relevant jets that are sustained over time scales 100 times the laser pulse duration (i.e., >70 ns), even in the case of strong variability at the source.
Collapse
Affiliation(s)
- D P Higginson
- Laboratoire pour l'Utilisation des Lasers Intenses-CNRS, CEA, École Polytechnique, Univ. Paris-Saclay, Sorbonne Univ., UPMC Univ. Paris 06, F-91128 Palaiseau cedex, France
- Lawrence Livermore National Laboratory, Livermore, California 94551, USA
| | - B Khiar
- Sorbonne Univ., UPMC Univ. Paris 6, UMR 8112, LERMA, F-75005 Paris, France
- LERMA, Observatoire de Paris, PSL Research University, CNRS, UMR 8112, F-75014 Paris, France
| | - G Revet
- Laboratoire pour l'Utilisation des Lasers Intenses-CNRS, CEA, École Polytechnique, Univ. Paris-Saclay, Sorbonne Univ., UPMC Univ. Paris 06, F-91128 Palaiseau cedex, France
- Institute of Applied Physics, 46 Ulyanov Street, 603950 Nizhny Novgorod, Russia
| | - J Béard
- LNCMI, UPR 3228, CNRS-UGA-UPS-INSA, 31400 Toulouse, France
| | - M Blecher
- Institut für Laser- und Plasmaphysik, Heinrich-Heine-Universität Düsseldorf, D-40225 Düsseldorf, Germany
| | - M Borghesi
- Centre for Plasma Physics, Queen's University Belfast, Belfast BT7 1NN, United Kingdom
| | - K Burdonov
- Institute of Applied Physics, 46 Ulyanov Street, 603950 Nizhny Novgorod, Russia
| | - S N Chen
- Laboratoire pour l'Utilisation des Lasers Intenses-CNRS, CEA, École Polytechnique, Univ. Paris-Saclay, Sorbonne Univ., UPMC Univ. Paris 06, F-91128 Palaiseau cedex, France
- Institute of Applied Physics, 46 Ulyanov Street, 603950 Nizhny Novgorod, Russia
| | - E Filippov
- Joint Institute for High Temperatures, RAS, 125412 Moscow, Russia
- National Research Nuclear University "MEPhI," 115409 Moscow, Russia
| | - D Khaghani
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - K Naughton
- Centre for Plasma Physics, Queen's University Belfast, Belfast BT7 1NN, United Kingdom
| | - H Pépin
- INRS-ÉMT, 1650 bd. L. Boulet, J3X1S2 Varennes, Québec, Canada
| | - S Pikuz
- Joint Institute for High Temperatures, RAS, 125412 Moscow, Russia
- National Research Nuclear University "MEPhI," 115409 Moscow, Russia
| | - O Portugall
- LNCMI, UPR 3228, CNRS-UGA-UPS-INSA, 31400 Toulouse, France
| | - C Riconda
- LULI, Sorbonne Univ.-UPMC Univ. Paris 06, École Polytechnique, CNRS, CEA, 75005 Paris, France
| | - R Riquier
- Laboratoire pour l'Utilisation des Lasers Intenses-CNRS, CEA, École Polytechnique, Univ. Paris-Saclay, Sorbonne Univ., UPMC Univ. Paris 06, F-91128 Palaiseau cedex, France
- CEA, DAM, DIF, 91297 Arpajon, France
| | - R Rodriguez
- Departamento de Fisica de la Universidad de Las Palmas de Gran Canaria, E-35017 Las Palmas de Gran Canaria, Spain
| | - S N Ryazantsev
- Joint Institute for High Temperatures, RAS, 125412 Moscow, Russia
- M.V. Lomonosov Moscow State University, 119991 Moscow, Russia
| | - I Yu Skobelev
- Joint Institute for High Temperatures, RAS, 125412 Moscow, Russia
- National Research Nuclear University "MEPhI," 115409 Moscow, Russia
| | - A Soloviev
- Institute of Applied Physics, 46 Ulyanov Street, 603950 Nizhny Novgorod, Russia
| | - M Starodubtsev
- Institute of Applied Physics, 46 Ulyanov Street, 603950 Nizhny Novgorod, Russia
| | - T Vinci
- Laboratoire pour l'Utilisation des Lasers Intenses-CNRS, CEA, École Polytechnique, Univ. Paris-Saclay, Sorbonne Univ., UPMC Univ. Paris 06, F-91128 Palaiseau cedex, France
| | - O Willi
- Institut für Laser- und Plasmaphysik, Heinrich-Heine-Universität Düsseldorf, D-40225 Düsseldorf, Germany
| | - A Ciardi
- Sorbonne Univ., UPMC Univ. Paris 6, UMR 8112, LERMA, F-75005 Paris, France
- LERMA, Observatoire de Paris, PSL Research University, CNRS, UMR 8112, F-75014 Paris, France
| | - J Fuchs
- Laboratoire pour l'Utilisation des Lasers Intenses-CNRS, CEA, École Polytechnique, Univ. Paris-Saclay, Sorbonne Univ., UPMC Univ. Paris 06, F-91128 Palaiseau cedex, France
- Institute of Applied Physics, 46 Ulyanov Street, 603950 Nizhny Novgorod, Russia
| |
Collapse
|
33
|
Andrade F, Salazar A, Naguib M, Rodriguez R, Carugno J. Perioperative Morbidity Associated with Abdominal Myomectomy Compared with Abdominal Hysterectomy for Very Large Fibroid Uterus. J Minim Invasive Gynecol 2017. [DOI: 10.1016/j.jmig.2017.08.571] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
34
|
Nakae S, Rojas Marquez D, Di Bartolo IM, Rodriguez R. Considerations for Residency Programs Regarding Accepting Undocumented Students Who Are DACA Recipients. Acad Med 2017; 92:1549-1554. [PMID: 28562450 DOI: 10.1097/acm.0000000000001731] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
The Deferred Action for Childhood Arrivals (DACA) initiative provides for the temporary deferral of enforcement of immigration laws for certain undocumented individuals brought to the United States before age 16. More than 50 medical schools now consider applicants who are DACA recipients, and medical school graduates with DACA are eligible to continue their training in graduate medical education. In this article, the authors summarize current policy and provide data on DACA recipients in medical school. They then review the implications for considering DACA recipients in graduate medical education, including employment guidelines, employer responsibilities, training at Veterans Affairs facilities, research funding, and professional licensure. They conclude by discussing the future of the DACA program and best practices for supporting students who are DACA recipients.First, there are no employment restrictions for DACA recipients with valid work authorization documents as long as their employers use Form I-9 Employment Eligibility Verification. Second, unlike H-1B or J-1 visa holders, DACA recipients do not generate additional immigration-related costs for their residency programs. Next, provisions in the Civil Rights Act prohibit employers from discriminating against applicants based on national origin or, in some cases, citizenship status. Furthermore, trainees with DACA are eligible to rotate through Veterans Affairs facilities. Finally, some states, like California and New York, have adopted policies and regulations allowing trainees with DACA who meet all professional requirements to receive a medical license. Given this state of affairs, DACA recipients should have equal standing to their peers when being evaluated for residency positions.
Collapse
Affiliation(s)
- Sunny Nakae
- S. Nakae is assistant dean for admissions, recruitment, and student life and assistant professor of medical education, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois. D. Rojas Marquez is a third-year medical student, Icahn School of Medicine at Mount Sinai, New York, New York, and founding member, Pre-Health Dreamers, San Francisco, California. I.M. Di Bartolo is a first-year internal medicine resident, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. R. Rodriguez is a first-year family medicine resident, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California
| | | | | | | |
Collapse
|
35
|
Probst M, Gupta M, Hendey G, Rodriguez R, Winkel G, Mower W. 371 Prevalence of Intracranial Injury in Blunt Head Trauma Patients With or Without Anticoagulant and Antiplatelet Use. Ann Emerg Med 2017. [DOI: 10.1016/j.annemergmed.2017.07.341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
36
|
Affiliation(s)
- R.-D. Penzhorn
- Kernforschungszentrum Karlsruhe Institut für Radiochemie Postfach 36 40, D-7500 Karlsruhe, F.R.G. (07247/82-3239)
| | - R. Rodriguez
- Kernforschungszentrum Karlsruhe Institut für Radiochemie Postfach 36 40, D-7500 Karlsruhe, F.R.G. (07247/82-3239)
| | - M. Glugla
- Kernforschungszentrum Karlsruhe Institut für Radiochemie Postfach 36 40, D-7500 Karlsruhe, F.R.G. (07247/82-3239)
| | - K. Günther
- Kernforschungszentrum Karlsruhe Institut für Radiochemie Postfach 36 40, D-7500 Karlsruhe, F.R.G. (07247/82-3239)
| | - H. Yoshida
- Japan Atomic Energy Research Institute Division of Thermonuclear Fusion Research Tokai-mura, Ibaraki-ken, Japan
| | - S. Konishi
- Japan Atomic Energy Research Institute Division of Thermonuclear Fusion Research Tokai-mura, Ibaraki-ken, Japan
| |
Collapse
|
37
|
Suzuki-Vidal F, Clayson T, Stehlé C, Swadling GF, Foster JM, Skidmore J, Graham P, Burdiak GC, Lebedev SV, Chaulagain U, Singh RL, Gumbrell ET, Patankar S, Spindloe C, Larour J, Kozlova M, Rodriguez R, Gil JM, Espinosa G, Velarde P, Danson C. Counterpropagating Radiative Shock Experiments on the Orion Laser. Phys Rev Lett 2017; 119:055001. [PMID: 28949745 DOI: 10.1103/physrevlett.119.055001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/11/2016] [Indexed: 06/07/2023]
Abstract
We present new experiments to study the formation of radiative shocks and the interaction between two counterpropagating radiative shocks. The experiments are performed at the Orion laser facility, which is used to drive shocks in xenon inside large aspect ratio gas cells. The collision between the two shocks and their respective radiative precursors, combined with the formation of inherently three-dimensional shocks, provides a novel platform particularly suited for the benchmarking of numerical codes. The dynamics of the shocks before and after the collision are investigated using point-projection x-ray backlighting while, simultaneously, the electron density in the radiative precursor was measured via optical laser interferometry. Modeling of the experiments using the 2D radiation hydrodynamic codes nym and petra shows very good agreement with the experimental results.
Collapse
Affiliation(s)
- F Suzuki-Vidal
- Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
| | - T Clayson
- Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
| | - C Stehlé
- Laboratoire d'Etude du Rayonnement et de la Matière en Astrophysique et Atmosphères (LERMA), Centre National de la Recherche Scientifique (CNRS), Observatoire de Paris, PSL Research University, Université Pierre et Marie Curie (UPMC), Sorbonne University, 4 Place Jussieu, 75252 Paris, France
| | - G F Swadling
- Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
| | - J M Foster
- Atomic Weapons Establishment (AWE), Aldermaston, Reading, West Berkshire RG7 4PR, United Kingdom
| | - J Skidmore
- Atomic Weapons Establishment (AWE), Aldermaston, Reading, West Berkshire RG7 4PR, United Kingdom
| | - P Graham
- Atomic Weapons Establishment (AWE), Aldermaston, Reading, West Berkshire RG7 4PR, United Kingdom
| | - G C Burdiak
- Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
| | - S V Lebedev
- Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
| | - U Chaulagain
- Laboratoire d'Etude du Rayonnement et de la Matière en Astrophysique et Atmosphères (LERMA), Centre National de la Recherche Scientifique (CNRS), Observatoire de Paris, PSL Research University, Université Pierre et Marie Curie (UPMC), Sorbonne University, 4 Place Jussieu, 75252 Paris, France
| | - R L Singh
- Laboratoire d'Etude du Rayonnement et de la Matière en Astrophysique et Atmosphères (LERMA), Centre National de la Recherche Scientifique (CNRS), Observatoire de Paris, PSL Research University, Université Pierre et Marie Curie (UPMC), Sorbonne University, 4 Place Jussieu, 75252 Paris, France
| | - E T Gumbrell
- Atomic Weapons Establishment (AWE), Aldermaston, Reading, West Berkshire RG7 4PR, United Kingdom
| | - S Patankar
- Atomic Weapons Establishment (AWE), Aldermaston, Reading, West Berkshire RG7 4PR, United Kingdom
| | - C Spindloe
- Science and Technology Facilities Council, Rutherford Appleton Laboratory, Harwell Campus, Chilton, Didcot, Oxon OX11 0QX, United Kingdom
| | - J Larour
- Laboratoire de Physique des Plasmas (LPP), Centre National de la Recherche Scientifique (CNRS), Ecole Polytechnique, Université Pierre et Marie Curie, Université Paris-Saclay, Sorbonne University, PSL Research University, 4 Place Jussieu, 75252 Paris, France
| | - M Kozlova
- Extreme Light Infrastructure (ELI), Institute of Plasma Physics, Czech Academy of Sciences, 182 00 Prague 8, Czech Republic
| | - R Rodriguez
- Departamento de Fisica, Universidad de Las Palmas de Gran Canaria, 35003 Las Palmas de Gran Canaria, Las Palmas, Spain
| | - J M Gil
- Departamento de Fisica, Universidad de Las Palmas de Gran Canaria, 35003 Las Palmas de Gran Canaria, Las Palmas, Spain
| | - G Espinosa
- Departamento de Fisica, Universidad de Las Palmas de Gran Canaria, 35003 Las Palmas de Gran Canaria, Las Palmas, Spain
| | - P Velarde
- Instituto de Fusion Nuclear, Universidad Politecnica de Madrid, 28040 Madrid, Spain
| | - C Danson
- Atomic Weapons Establishment (AWE), Aldermaston, Reading, West Berkshire RG7 4PR, United Kingdom
| |
Collapse
|
38
|
Zegri Reiriz I, Dominguez F, De Alarcon A, Munoz P, Martinez-Selles M, Gonzalez-Ramallo V, Miro J, Falces C, Gonzalez-Rico C, Kortajarena -Urkola X, Lepe J, Rodriguez R, Reguera-Iglesias J, Navas E, Garcia-Pavia P. P4542Infective endocarditis antibiotic prophylaxis in mitral valve prolapse and bicuspid aortic valve: should it be considered? Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.p4542] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- I. Zegri Reiriz
- University Hospital Puerta de Hierro Majadahonda, Department of Cardiology, Madrid, Spain
| | - F. Dominguez
- University Hospital Puerta de Hierro Majadahonda, Department of Cardiology, Madrid, Spain
| | - A. De Alarcon
- Institute of Biomedicine of Seville (IBIS), Seville, Spain
| | - P. Munoz
- University Hospital Gregorio Maranon, Department of Microbiology and Infectious Disease, Madrid, Spain
| | - M. Martinez-Selles
- University Hospital Gregorio Maranon, Department of Cardiology, Madrid, Spain
| | - V. Gonzalez-Ramallo
- University Hospital Gregorio Maranon, Department of General Medicine, Madrid, Spain
| | - J.M. Miro
- Hospital Clinic de Barcelona, Department of Cardiology, Barcelona, Spain
| | - C. Falces
- Hospital Clinic de Barcelona, Department of Cardiology, Barcelona, Spain
| | - C. Gonzalez-Rico
- University Hospital Marques de Valdecilla, Department of Infectious Disease, Santander, Spain
| | | | - J.A. Lepe
- Institute of Biomedicine of Seville (IBIS), Seville, Spain
| | - R. Rodriguez
- Hospital de Cruces, Department of Infectious Disease, Bilbao, Spain
| | - J.M. Reguera-Iglesias
- Regional University Hospital of Malaga, Department of Infectious Disease, Malaga, Spain
| | - E. Navas
- University Hospital Ramon y Cajal de Madrid, Department of Infectious Disease, Madrid, Spain
| | - P. Garcia-Pavia
- University Hospital Puerta de Hierro Majadahonda, Department of Cardiology, Madrid, Spain
| | | |
Collapse
|
39
|
De la Calle M, Baquero F, Rodriguez R, González M, Fernández A, Omeñaca F, Bartha JL. Successful treatment of intrauterine cytomegalovirus infection with an intraventricular cyst in a dichorionic diamniotic twin gestation using cytomegalovirus immunoglobulin. J Matern Fetal Neonatal Med 2017; 31:2226-2229. [PMID: 28573940 DOI: 10.1080/14767058.2017.1338259] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
Congenital cytomegalovirus (CMV) infection is the leading cause of severe congenital abnormalities. CMV immunoglobulin (CMVIG) may lower risk for symptomatic disease in congenital CMV infection. In a twin pregnancy, only one fetus shows CMV infection, raising a dilemma about intervention since the uninfected fetus would be exposed to treatment unnecessarily. CMVIG (2 × 200 U/kg) was given due to high viral load and development of an intraventricular cyst. The cyst growth plateaued, no other brain damage developed, and at 8 months, the infant was symptom-free. CMVIG appears appropriate to treat intrauterine CMV infection in this setting.
Collapse
Affiliation(s)
- M De la Calle
- a Department of Obstetrics and Gynaecology, Maternal-Fetal Medicine Unit , La Paz University Hospital , Madrid , Spain
| | - F Baquero
- b Department of Pediatric Infectology , La Paz University Hospital , Madrid , Spain
| | - R Rodriguez
- a Department of Obstetrics and Gynaecology, Maternal-Fetal Medicine Unit , La Paz University Hospital , Madrid , Spain
| | - M González
- a Department of Obstetrics and Gynaecology, Maternal-Fetal Medicine Unit , La Paz University Hospital , Madrid , Spain
| | - A Fernández
- c Department of Radiology , La Paz University Hospital , Madrid , Spain
| | - F Omeñaca
- d Department of Neonatology , La Paz University Hospital , Madrid , Spain
| | - J L Bartha
- a Department of Obstetrics and Gynaecology, Maternal-Fetal Medicine Unit , La Paz University Hospital , Madrid , Spain
| |
Collapse
|
40
|
Dang S, Thavalathil B, Ruiz D, Gomez-Orozco C, Caralis P, Gomez-Marin O, Levis S, Rodriguez R. ENHANCING COMMUNICATION AND SHARED DECISION MAKING VIA ELECTRONIC HEALTH RECORDS. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.2085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- S. Dang
- Miami Veterans Affairs Healthcare System, Miami, Florida,
- Miami VA Geriatric Research Education and Clinical Center, Miami, Florida,
- University of Miami Miller School of Medicine, Miami, Florida,
| | - B. Thavalathil
- South Florida Veterans Affairs Foundation for Research and Education, Miami, Florida
| | - D. Ruiz
- Miami Veterans Affairs Healthcare System, Miami, Florida,
| | - C. Gomez-Orozco
- South Florida Veterans Affairs Foundation for Research and Education, Miami, Florida
| | - P. Caralis
- Miami Veterans Affairs Healthcare System, Miami, Florida,
| | - O. Gomez-Marin
- South Florida Veterans Affairs Foundation for Research and Education, Miami, Florida
| | - S. Levis
- Miami Veterans Affairs Healthcare System, Miami, Florida,
- Miami VA Geriatric Research Education and Clinical Center, Miami, Florida,
- University of Miami Miller School of Medicine, Miami, Florida,
| | - R. Rodriguez
- Miami Veterans Affairs Healthcare System, Miami, Florida,
| |
Collapse
|
41
|
Mcinnis D, Hendrichs J, Shelly T, Barr N, Hoffman K, Rodriguez R, Lance D, Bloem K, Suckling D, Enkerlin W, Gomes P, Tan K. Can Polyphagous Invasive Tephritid Pest Populations Escape Detection for Years Under Favorable Climatic and Host Conditions? ACTA ACUST UNITED AC 2017. [DOI: 10.1093/ae/tmx038] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
42
|
Balogun A, Armijos R, Weigel M, Cevallos W, Sanchez X, Puebla E, Rodriguez R. Epidemiology of Cutaneous Leishmaniasis in an Endemic Pacific Coastal
Rainforest Area of Ecuador. Ann Glob Health 2017. [DOI: 10.1016/j.aogh.2017.03.133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
43
|
Wang Y, Armijos R, Weigel M, Balogun A, Sorocco T, Cevallos W, Sanchez X, Puebla E, Rodriguez R. Diagnosis of Cutaneous Leishmaniasis using Microscopic Detection and
Molecular-based PCR Assay Techniques. Ann Glob Health 2017. [DOI: 10.1016/j.aogh.2017.03.374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
44
|
Aqeel Y, Rodriguez R, Chatterjee A, Ingalls RR, Samuelson J. Killing of diverse eye pathogens (Acanthamoeba spp., Fusarium solani, and Chlamydia trachomatis) with alcohols. PLoS Negl Trop Dis 2017; 11:e0005382. [PMID: 28182670 PMCID: PMC5321442 DOI: 10.1371/journal.pntd.0005382] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2016] [Revised: 02/22/2017] [Accepted: 02/02/2017] [Indexed: 12/18/2022] Open
Abstract
Background Blindness is caused by eye pathogens that include a free-living protist (Acanthamoeba castellanii, A. byersi, and/or other Acanthamoeba spp.), a fungus (Fusarium solani), and a bacterium (Chlamydia trachomatis). Hand-eye contact is likely a contributor to the spread of these pathogens, and so hand washing with soap and water or alcohol–based hand sanitizers (when water is not available) might reduce their transmission. Recently we showed that ethanol and isopropanol in concentrations present in hand sanitizers kill walled cysts of Giardia and Entamoeba, causes of diarrhea and dysentery, respectively. The goal here was to determine whether these alcohols might kill infectious forms of representative eye pathogens (trophozoites and cysts of Acanthamoeba, conidia of F. solani, or elementary bodies of C. trachomatis). Methodology/Principal findings We found that treatment with 63% ethanol or 63% isopropanol kills >99% of Acanthamoeba trophozoites after 30 sec exposure, as shown by labeling with propidium iodide (PI) and failure to grow in culture. In contrast, Acanthamoeba cysts, which contain cellulose fibers in their wall, are relatively more resistant to these alcohols, particularly isopropanol. Depending upon the strain tested, 80 to 99% of Acanthamoeba cysts were killed by 63% ethanol after 2 min and 95 to 99% were killed by 80% ethanol after 30 sec, as shown by PI labeling and reduced rates of excystation in vitro. Both ethanol and isopropanol (63% for 30 sec) kill >99% of F. solani conidia, which have a wall of chitin and glucan fibrils, as demonstrated by PI labeling and colony counts on nutrient agar plates. Both ethanol and isopropanol (63% for 60 sec) inactivate 96 to 99% of elementary bodies of C. trachomatis, which have a wall of lipopolysaccharide but lack peptidoglycan, as measured by quantitative cultures to calculate inclusion forming units. Conclusions/Significance In summary, alcohols kill infectious forms of Acanthamoeba, F. solani, and C. trachomatis, although longer times and higher ethanol concentrations are necessary for Acanthamoeba cysts. These results suggest the possibility that expanded use of alcohol-based hand sanitizers in places where water is not easily available might reduce transmission of these important causes of blindness. Hand washing with soap and water is an important public health tool for reducing transmission of viruses, bacteria, fungi, and protists. Alcohol-based hand sanitizers, which are widely dispensed in hospitals and public places, kill many of these same pathogens. What is not known is how effectively the alcohol-based hand sanitizers kill protists, fungi, or bacteria that cause eye disease. Here we show ethanol and isopropanol penetrate the walls and kill a free-living protist (Acanthamoeba castellanii, A. byersi, and other Acanthamoeba spp.), and a fungus (Fusarium solani), each of which causes keratitis, as well as a bacterium (Chlamydia trachomatis) that causes trachoma. These results suggest the possible benefit of hand sanitizers in the prevention of these eye pathogens.
Collapse
Affiliation(s)
- Yousuf Aqeel
- Department of Molecular and Cell Biology, Boston University Goldman School of Dental Medicine, Boston, Massachusetts, United States of America
| | - Raquel Rodriguez
- Department of Medicine, Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts, United States of America
- Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America
| | - Aparajita Chatterjee
- Department of Molecular and Cell Biology, Boston University Goldman School of Dental Medicine, Boston, Massachusetts, United States of America
| | - Robin R. Ingalls
- Department of Medicine, Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts, United States of America
- Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America
| | - John Samuelson
- Department of Molecular and Cell Biology, Boston University Goldman School of Dental Medicine, Boston, Massachusetts, United States of America
- Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America
- * E-mail:
| |
Collapse
|
45
|
Moore L, Marshall G, Seals S, Rodriguez R, Yates A, Dave N. P126 Assessment of pediatric asthma care by primary care providers in mississippi using an online questionnaire. Ann Allergy Asthma Immunol 2016. [DOI: 10.1016/j.anai.2016.09.136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
46
|
Murphy C, Rodriguez R. 302 Rib Fractures in the PanScan Era. Ann Emerg Med 2016. [DOI: 10.1016/j.annemergmed.2016.08.318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
47
|
Ordonez JZ, Ángel-García O, Carrillo E, Luna-Orozco J, Meza-Herrera CA, Rodriguez R, Véliz-Deras FG. 1691 Induction of sexual activity in Dorper ewes: Effect of two intramuscular doses of progesterone vs. progesterone vaginal sponges + eCG. J Anim Sci 2016. [DOI: 10.2527/jam2016-1691] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
48
|
Santos Z, Meza-Herrera CA, Guillen JM, Arellano F, Rodriguez R, Véliz-Deras FG. 1697 Post-estrus GnRH administration does not improve fertility in Alpine goats in northern Mexico. J Anim Sci 2016. [DOI: 10.2527/jam2016-1697] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
49
|
Esparza D, Rodriguez R, Veliz FG, Angel O, Arbez T, Robles-Trillo P. 1659 Effect of peNDF on milk production and composition in goats fed with NNFS replacing alfalfa hay. J Anim Sci 2016. [DOI: 10.2527/jam2016-1659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
50
|
Martinez-Cruzado L, Tornin J, Santos L, Rodriguez A, Rodriguez R. ALDH1 expression and activity increase during tumor evolution in sarcoma cancer stem cell populations. Eur J Cancer 2016. [DOI: 10.1016/s0959-8049(16)61301-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|